Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...

Roche’s CD20xCD3 bispecific antibody Columvi has improved survival when used as a second-line therapy for diffuse large B-cell lymphoma (DLBCL) in a phase 3 trial, setting up regulatory filings for ...

Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis. The US biotech has just ...

U.S. destroys 16 Iranian naval vessels in Strait of Hormuz to prevent mine-laying, as conflict widens and oil prices surge toward $120.

Acurx Pharmaceuticals, Inc.  ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today announced ...

Vertex Pharmaceuticals (NASDAQ:VRTX) shares rose 6% to $488.52 in premarket trading Thursday after the company reported successful results from a late-stage trial ...

Acurx's Program in the Broader CDI Patient Population is Ready to Advance toPhase 3 International Clinical Trials Acurx is launching a ground-breaking clinical trial ...

Vertex Pharmaceuticals (NASDAQ:VRTX) shares climbed about 6% to $488.52 in premarket trading Thursday after the company reported encouraging results from a late-stage clinical trial of its kidney ...

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Ramaco Resources, Inc. (NASDAQ: METC) between July 31, 2025 and October 23, 2025, both dates inclusive (the ...

⚓ Navy uniforms ⭐ Broadway coming to S.D. 🌿 Garden tours guide 🛒 Grocery Outlet closures 🎷 Humphreys turns 45 The board is mulling changes that could have a big impact on the annual cost, and ...